We are live on ! Find out more
LA

Linden Advisors Portfolio holdings

AUM $17.9B
1-Year Est. Return 1.72%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+1.72%
3 Year Est. Return
+2.79%
5 Year Est. Return
+3.4%
10 Year Est. Return
+25.58%
AUM
$16.2B
AUM Growth
+$1.25B
Cap. Flow
-$11.2B
Cap. Flow %
-68.71%
Top 10 Hldgs %
24.75%
Holding
515
New
100
Increased
15
Reduced
8
Closed
43

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$33.3M
2
RNGT
Range Capital Acquisition Corp II
RNGT
+$17.3M
3
TLNC
Talon Capital Corp
TLNC
+$16.3M
4
SCIIU
SC II Acquisition Corp Units
SCIIU
+$15.1M
5
IRHOU
Iron Horse Acquisitions II Corp Units
IRHOU
+$14.9M

Top Sells

Rank Stock Value
1
NVMI
Nova
NVMI
+$29.1M
2
BXP icon
Boston Properties
BXP
+$18.7M
3
TLNCU
Talon Capital Corp Units
TLNCU
+$15M
4
MKLYU
McKinley Acquisition Corp Units
MKLYU
+$14.4M
5
GSRFU
GSR IV Acquisition Corp Units
GSRFU
+$12.7M

Sector Composition

Rank Sector Weight
1 Financials 6.22%
2 Healthcare 0.2%
3 Energy 0.19%
4 Industrials 0.11%
5 Consumer Staples 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBPEW
301
XBP Europe Holdings Warrant
XBPEW
$29K ﹤0.01%
1,040,133
– –
HAVAR
302
Harvard Ave Acquisition Corp Rights
HAVAR
$28.8K ﹤0.01%
+250,000
New +$29.8K
MMTXW
303
Miluna Acquisition Corp Warrant
MMTXW
$27.5K ﹤0.01%
+250,000
New +$25K
LAFAR
304
LaFayette Acquisition Corp Rights
LAFAR
$26.7K ﹤0.01%
+175,000
New +$25.5K
PSQH.WS icon
305
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.14M
$26.7K ﹤0.01%
275,024
– –
TVGNW icon
306
Tevogen Bio Warrant
TVGNW
$9.64M
$25K ﹤0.01%
649,999
– –
BDMDW
307
Baird Medical Investment Holdings Warrant
BDMDW
$24.2K ﹤0.01%
435,179
– –
ESHAR
308
DELISTED
ESH Acquisition Corp Right
ESHAR
$22.5K ﹤0.01%
100,000
– –
HPAIW
309
Helport AI Warrants
HPAIW
$377K
$22.3K ﹤0.01%
133,265
– –
SCAGW
310
Scage Future Warrants
SCAGW
$576K
$20K ﹤0.01%
318,749
– –
FIGXW
311
FIGX Capital Acquisition Corp Warrant
FIGXW
$2.18M
$19.9K ﹤0.01%
75,001
– –
MRNOW
312
Murano Global Investments PLC Warrants
MRNOW
$218K
$19.7K ﹤0.01%
749,999
– –
FCRS.WS
313
FutureCrest Acquisition Corp Warrants
FCRS.WS
$19.6K ﹤0.01%
+24,999
New +$19.5K
LANV.WS
314
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$18K ﹤0.01%
1,138,687
– –
ASBPW
315
Aspire Biopharma Warrant
ASBPW
$579K
$17.7K ﹤0.01%
899,999
– –
TALKW
316
DELISTED
Talkspace Inc Warrant
TALKW
$16.1K ﹤0.01%
1,071,902
– –
NVNIW
317
Nvni Group Limited Warrants
NVNIW
$15.6K ﹤0.01%
249,999
– –
CRACW
318
Crown Reserve Acquisition Corp I Warrant
CRACW
$10.9K ﹤0.01%
+125,000
New +$11.2K
LIMNW
319
Liminatus Pharma Warrants
LIMNW
$318K
$10.6K ﹤0.01%
268,199
– –
GCLWW
320
GCL Global Holdings Warrants
GCLWW
$9.75K ﹤0.01%
375,000
– –
ZOOZW
321
ZOOZ Strategy Ltd Warrant
ZOOZW
$170K
$9.41K ﹤0.01%
254,999
– –
CELUW
322
DELISTED
Celularity Inc
CELUW
$8.97K ﹤0.01%
550,119
– –
SLXNW
323
Silexion Therapeutics Warrant
SLXNW
$178K
$8.57K ﹤0.01%
337,500
– –
ABPWW
324
DELISTED
Abpro Holdings Warrant
ABPWW
$8.5K ﹤0.01%
499,999
– –
LMND.WS
325
DELISTED
Lemonade Inc Warrants
LMND.WS
$7.95K ﹤0.01%
324,359
– –
11 12
13
14 15

Similar funds

MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
CWP
Capital Wealth Planning Naples, Florida $18.1B AUM 26.68% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $18.3B AUM 27.14% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FAF
Fjarde Ap-fonden Stockholm, Sweden $18.3B AUM 23.23% 1-Year Est. Return
NC
Nvidia Corp Santa Clara, California $18.4B AUM 362.26% 1-Year Est. Return

Linden Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Linden Advisors held 515 positions worth $16.2B, up 8.3% from $15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Linden Advisors withdrew a net $11.2B in Q4 2025, closing 43 positions and reducing 8 holdings. Its most notable exit was Nova, an estimated $29.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 5.1% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Linden Advisors opened a new position in Zoetis worth $32.1M.

  • Linden Advisors's largest Q4 2025 buy was Zoetis: 255,200 shares worth $32.1M.
  • Linden Advisors added most to Andretti Acquisition Corp II in Q4 2025, an estimated $7.39M increase.
  • Linden Advisors's biggest Q4 2025 reduction was Core Scientific Inc Tranche 1 Warrants, cutting an estimated $8.88M.
  • Linden Advisors fully exited Nova in Q4 2025, selling an estimated $29.1M.
  • Linden Advisors's ten largest holdings make up 25% of its $16.2B portfolio in Q4 2025.
  • Linden Advisors opened 100 new positions and closed 43 in Q4 2025.
  • Linden Advisors's portfolio value rose 8.3% quarter-over-quarter to $16.2B.

Based on Linden Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.